Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Kelli Mauric

Kelli Mauric

Owner / Entreprenuer at Balance the Brain Professional Corp USA

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Cancer Stem Cells 2024

About Conference


With great enthusiasm, we announce the 15th International Conference on Cancer Stem Cell & Oncology Research, scheduled for September 19-20, 2024, in the enchanting city of Paris, France. Under the distinguished theme of "Tumor Heterogeneity and Plasticity: Challenges and Opportunities in Cancer Stem Cell Research," CANCER STEM CELLS 2024 aims to convene leading scientists, researchers, clinicians, and industry experts from around the globe.

This prestigious gathering will delve into the intricate world of cancer stem cells, exploring their role in tumor heterogeneity and plasticity. Through insightful discussions, keynote presentations, panel sessions, and poster presentations, attendees will gain profound insights into the latest advancements, challenges, and opportunities in cancer stem cell research.

Set against the backdrop of Paris, renowned for its rich history, culture, and scientific contributions, this conference promises to foster collaboration, innovation, and exchange of ideas in the field of oncology research. Join us at CANCER STEM CELLS 2024 to be part of this transformative journey towards conquering cancer through pioneering research and breakthrough discoveries.

Why Attend Cancer stem cells 2024?

CANCER STEM CELLS 2024 offers a unique opportunity for professionals in the field of oncology research to immerse themselves in a dynamic environment of learning, collaboration, and innovation. Here are compelling reasons why you should attend:

  1. Cutting-Edge Insights: Stay abreast of the latest advancements in cancer stem cell research and oncology. Gain insights into groundbreaking discoveries, emerging technologies, and novel therapeutic approaches.

  2. Networking Opportunities: Connect with leading scientists, researchers, clinicians, and industry experts from around the world. Forge valuable collaborations, exchange ideas, and establish professional relationships that can propel your research forward.

  3. Interdisciplinary Exchange: Engage in interdisciplinary discussions that transcend traditional boundaries. Explore synergies between different fields, fostering a holistic approach towards understanding and combating cancer.

  4. Professional Development: Enhance your knowledge and skills through keynote presentations, panel discussions, and interactive sessions led by experts in the field. Expand your professional horizons and stay ahead in your career.

  5. Inspiration and Motivation: Immerse yourself in a stimulating environment that fuels inspiration and motivation. Interact with pioneers in cancer research, hear their stories, and reignite your passion for making a difference in the fight against cancer.

  6. Global Perspective: Gain a global perspective on cancer stem cell research and oncology. Learn about diverse challenges and solutions from different regions, enriching your understanding and broadening your horizons.

  7. Explore Paris: Experience the vibrant culture, history, and charm of Paris, one of the world's most beloved cities. Take advantage of your time outside the conference to explore iconic landmarks, indulge in exquisite cuisine, and create lasting memories.

Don't miss the opportunity to be part of CANCER STEM CELLS 2024 and contribute to advancing the frontiers of cancer research. Join us in Paris for an enriching and transformative experience!

Who Can Attend?

  1. Research Scientists: Esteemed researchers at the forefront of cancer stem cell biology, oncology, and related disciplines, whose work is pivotal in uncovering novel insights and therapeutic targets.

  2. Clinical Oncologists: Experienced clinicians specializing in the diagnosis, treatment, and management of cancer patients, including medical oncologists, radiation oncologists, surgical oncologists, and pediatric oncologists.

  3. Academic Scholars: Professors, educators, and scholars from academic institutions dedicated to teaching, mentoring, and conducting research in cancer biology, stem cell biology, and oncology.

  4. Biotechnology and Pharmaceutical Professionals: Industry experts involved in the development and commercialization of innovative therapies, drugs, and technologies aimed at combating cancer and improving patient outcomes.

  5. Graduate Students and Postdoctoral Fellows: Aspiring scientists pursuing advanced degrees or postdoctoral training in cancer research, seeking to expand their knowledge, network with peers, and showcase their research findings.

  6. Policy Makers and Advocates: Government officials, policymakers, and advocacy groups committed to shaping policies, funding initiatives, and public health strategies to address the challenges posed by cancer at local, national, and global levels.

  7. International Delegates: Professionals from around the world who are dedicated to fostering international collaboration and cooperation in cancer research, sharing best practices, and addressing disparities in cancer prevention, diagnosis, and treatment.

In essence, the Conference on Cancer Stem Cell & Oncology Research welcomes professionals from diverse backgrounds and specialties, united by their shared commitment to advancing the field of oncology and improving patient care.

Session & Track

Track 1: Cancer Stem Cell Biology

Latest insights into the molecular mechanisms governing cancer stem cell self-renewal and differentiation.

Track 2: Tumor Microenvironment

Understanding the dynamic interplay between cancer stem cells and the tumor microenvironment in tumor progression and therapy resistance.

Track 3: Therapeutic Targeting

Novel therapeutic targets and strategies for specifically targeting and eradicating cancer stem cells.

Track 4: Immunotherapy

Harnessing the immune system to target and eliminate cancer stem cells, with a focus on immune checkpoint inhibitors and adoptive cell therapy.

Track 5: Metabolic Reprogramming

Metabolic plasticity of cancer stem cells and its implications for tumor growth, therapy response, and metabolic vulnerabilities.

Track 6: Epigenetics

Epigenetic regulation of cancer stem cells and its role in tumor heterogeneity, therapeutic resistance, and cellular plasticity.

Track 7: Biomarkers and Imaging

Emerging biomarkers and imaging techniques for the detection, characterization, and monitoring of cancer stem cells in vivo.

Track 8: Clinical Trials

Insights from clinical trials evaluating novel therapies targeting cancer stem cells, including patient stratification and biomarker development.

Track 9: Stem Cell Niches

Role of stem cell niches in maintaining cancer stem cell populations and influencing tumor initiation, progression, and metastasis.

Track 10: Circulating Tumor Cells

Significance of circulating tumor cells and disseminated cancer stem cells in metastasis, therapy resistance, and minimal residual disease detection.

Track 11: Single-cell Analysis

Advances in single-cell analysis techniques for dissecting heterogeneity within cancer stem cell populations and identifying therapeutic vulnerabilities.

Track 12: Therapeutic Resistance

Mechanisms of therapeutic resistance in cancer stem cells and strategies to overcome resistance and improve treatment outcomes.

Track 13: Exosome Biology

Role of exosomes in mediating intercellular communication between cancer stem cells and the tumor microenvironment, with implications for tumor progression and therapy resistance.

Track 14: Artificial Intelligence

Application of artificial intelligence and machine learning in cancer stem cell research, including predictive modeling, drug discovery, and personalized medicine.

Track 15: Patient-Derived Models

Utility of patient-derived models, including organoids, patient-derived xenografts, and patient-derived tumor organoids, for studying cancer stem cell biology and drug screening.

Track 16: Pediatric Oncology

Unique challenges and opportunities in targeting cancer stem cells in pediatric cancers, with a focus on personalized therapies and long-term survivorship.

Track 17: Nanotechnology

Application of nanotechnology for targeted drug delivery, imaging, and theranostics in cancer stem cell research and therapy.

Track 18: Genome Editing

CRISPR-based approaches for studying cancer stem cells, including gene editing, functional genomics, and therapeutic applications.

Track 19: Environmental Factors

Impact of environmental factors, such as hypoxia, inflammation, and microbiome, on cancer stem cell biology and tumor progression.

Track 20: Ethical Considerations

Ethical and societal considerations in cancer stem cell research, including patient consent, privacy, and equitable access to emerging therapies.

 

Participant Options & Benefits

1. Conference Attendance:

  • Engage with leading experts and researchers in the field of cancer stem cell and oncology research.
  • Access cutting-edge presentations, keynote speeches, and panel discussions covering the latest advancements in tumor heterogeneity and plasticity.
  • Network with peers, collaborators, and potential partners from academia, industry, and healthcare sectors.

2. Presentation Opportunities:

  • Showcase your research findings, insights, and innovations through oral or poster presentations.
  • Gain valuable feedback and recognition from esteemed colleagues and mentors.
  • Elevate your professional profile and contribute to the advancement of cancer stem cell research.

3. Continuing Medical Education (CME) Credits:

  • Earn CME and CPD credits by participating in accredited sessions, workshops, and educational activities.
  • Stay updated with the latest developments and best practices in cancer stem cell and oncology research.
  • Enhance your professional credentials and meet licensure or certification requirements.

4. Knowledge Exchange:

  • Exchange ideas, methodologies, and best practices with fellow participants and thought leaders.
  • Collaborate on interdisciplinary projects and research initiatives addressing challenges in cancer stem cell biology and therapy.
  • Foster international collaborations and partnerships to accelerate progress in the field.

5. Access to Resources:

  • Gain access to conference materials, abstracts, and proceedings for reference and further study.
  • Explore exhibitor booths and resources showcasing cutting-edge technologies, products, and services in cancer research and therapy.
  • Access exclusive resources, tools, and publications to support ongoing research and professional development.

6. Professional Development:

  • Attend specialized workshops, training sessions, and skill-building activities tailored to your professional development needs.
  • Expand your knowledge, skills, and expertise in cancer stem cell biology, oncology research methodologies, and clinical practice.
  • Stay abreast of emerging trends, technologies, and opportunities shaping the future of cancer research and treatment.

7. Networking and Collaboration:

  • Connect with renowned experts, researchers, clinicians, and industry professionals during networking sessions and social events.
  • Initiate collaborations, partnerships, and research projects with potential collaborators and stakeholders.
  • Build lasting relationships and professional networks to support your career advancement and research endeavors.

Participate in the 15th International Conference on Cancer Stem Cell & Oncology Research to explore the challenges and opportunities in tumor heterogeneity and plasticity, while advancing your knowledge, skills, and professional connections in the field. Join us in Paris, France, on September 19-20, 2024, for an enriching and rewarding experience.

 

Market Analysis

The landscape of cancer research and therapy is continually evolving, driven by advancements in technology, innovative therapeutic approaches, and a growing understanding of the underlying biology of cancer. As we approach the 15th International Conference on Cancer Stem Cell & Oncology Research, it's essential to conduct a comprehensive market analysis to understand the current trends, challenges, and opportunities shaping the field.

1. Market Trends:

  • The cancer stem cell research market is witnessing steady growth, fueled by increasing investments in research and development, rising prevalence of cancer worldwide, and the emergence of novel therapeutic targets.
  • Advances in genomic profiling, single-cell analysis, and high-throughput screening technologies are revolutionizing cancer research, enabling researchers to unravel the complexities of tumor heterogeneity and plasticity.
  • Immunotherapy continues to garner significant attention and investment, with immune checkpoint inhibitors and adoptive cell therapies showing promising results in targeting cancer stem cells and improving patient outcomes.

2. Challenges:

  • Despite significant progress, challenges persist in translating basic research findings into clinical applications, particularly in identifying effective therapeutic targets and overcoming therapy resistance mechanisms.
  • Tumor heterogeneity poses a significant challenge in cancer treatment, necessitating personalized approaches to therapy and highlighting the importance of understanding the molecular and cellular drivers of individual tumors.
  • Ethical and regulatory considerations surrounding the use of emerging technologies, such as genome editing and nanotechnology, in cancer research and therapy require careful navigation to ensure responsible and ethical conduct

To Collaborate Scientific Professionals around the World

Conference Date September 19-20, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by